TB treatment: new drugs and drug resistance

Poster Discussion
Chairs: Christoph Lange (Borstel, Germany), Raquel Almeida Ferreira Duarte Bessa Melo (Porto, Portugal)
Minimal inhibitory concentrations (MICs) of mefloquine: in vitro activity against MDR- and nonMDR-Tb strains
David Krieger (Berlin, Germany), David Krieger, Silvan Vesenbeckh, Nicolas Schönfeld, Gudrun Bettermann, Holger Rüssmann, Harald Mauch, Torsten Bauer
Congress or journal article abstract
Congress or journal article abstract
Efficacy of moxifloxacin in TB resistant to isoniazid
Mykhailo Kuzhko (Kiev, Ukraine), Mykhailo Kuzhko, Ljubomyr Procyk, Leonid Grechanyk, Nataliia Gulchuk, Oksana Avramchuk, Mykola Gumeniuk
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Neuroleptic drugs as potential adjuvants in the treatment of MDR-TB: Minimal inhibitory concentrations (MICs) of different phenothiazines against M. tuberculosis
Silvan Vesenbeckh (Berlin, Germany), Silvan Vesenbeckh, David Krieger, Gudrun Bettermann, Nicolas Schönfeld, Holger Rüssmann, Harald Mauch, Torsten Bauer
Congress or journal article abstract
Congress or journal article abstract
Clofazimine for the treatment of multidrug-resistant tuberculosis: Prospective, multicenter, randomized controlled study in China
Shenjie Tang (Shanghai, China), Shenjie Tang, Lan Yao, Xiaohui Hao
Congress or journal article abstract
Congress or journal article abstract
Minimum inhibitory concentrations (MIC) determination of TB drugs and broad-spectrum antibiotics in M.tuberculosis with M/X/TDR
Sergejj Aleksandrovich Popov (Moscow, Russian Federation), Sergey Popov, Aleksey Kuzmin, Tamara Sabgayda, Nataly Vedenina
Congress or journal article abstract
Congress or journal article abstract
HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs
Florian von Groote-Bidlingmaier (Cape Town, South Africa), Sadiyya Sheik, Sweetness Siwendu, Melissa Mitchell, Andreas Henri Diacon, Florian Von Groote-Bidlingmaier
Congress or journal article abstract
Congress or journal article abstract
Rifampicin-resistant TB on Gene Xpert: What is the best empiric combination treatment while awaiting cultures?
Lancelot Pinto (Mumbai, India), Ujjwal Sharma, Chaitali Nikam, Radhika Banka, Camilla Rodrigues, Lancelot Pinto
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Evaluation of failures treated with linezolid-containing regimen for extensively drug-resistant tuberculosis (XDR-TB)
Myungsun Lee (Seoul, Republic of Korea), Myungsun Lee, Namsoo Rhu, Ji Yeon Lee, Joonsung Joh, Youngran Kim, Ina Jeong
Congress or journal article abstract
Congress or journal article abstract
Prospects for early implementation of ambulatory treatment in XDR TB patients by optimizing the administration of linezolid at the intensive phase of chemotherapy
Svitlana A. Cherenko (Kiev, Ukraine), Svitlana Cherenko, Nataliia Litvinenko
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Administration of linezolid, bedaquiline and imipenem in treatment of patients with extensively drug-resistant tuberculosis
Diljara Esmedlyaeva (St.Petersburg, Russian Federation), L.T. Nikolayan, L.M. Yeghiazaryan, A.O. Hayrapetyan, N.R. Beglaryan, V.R. Poghosyan
Congress or journal article abstract
Congress or journal article abstract
Impact of pre-treatment duration by first line drugs on treatment outcomes of patients with MDR-TB
Yana Batyrshina (Novosibirsk, Russian Federation), Yana Batyrshina
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Efficacy of treatment of MDR/XDR TB patients with diabetes mellitus
Irina Vasilyeva Anatolievna (Moscow, Russian Federation), Irina Vasilyeva, Anastasia Samoilova, Svetlana Moiseeva, Natalia Kuzmina, Natalia Musatova
Congress or journal article abstract
Congress or journal article abstract
Cost-effectiveness of treating MDR-TB by adding delamanid to background regimens in Germany
Roland Diel (Hamburg, Germany), Roland Diel, Norbert Hittel, Tom Schaberg
Congress or journal article abstract
Congress or journal article abstract
Electronic nose as a surrogate marker of response to treatment of pulmonary tuberculosis (ELNOSUR study)
Rosarito Coronel (Asuncion, Paraguay), Rosarito Coronel, Sandra Gonzalez, Cecile Magis-Escurra
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Evaluation of optimal regimens for treatment of rifampicin resistant-tuberculosis: Multicenter, randomized controlled study in China
Shenjie Tang (Shanghai, China), Shenjie Tang, Lan Yao, Xiaohui Hao, Yidian Liu
Congress or journal article abstract
Congress or journal article abstract
Should MRI be used to determine the duration of treatment in spinal tuberculosis?
Emily McGhee (Hertfordshire, United Kingdom), Emily McGhee, Kolera Chengappa, Ronan Breen, Jonathan Lucas, Heather Milburn
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
An incidence of the ethambutol-induced optic neuropathy and the usefulness of periodic visual acuity test – A questionnaire survey in Japan
Masataka Matsumoto (Miki, Japan), Masataka Matsumoto, Toshiyasu Sakurai, Kimihide Tada, Akihiko Ikeda, Tatsuo Kato, Takashi Yoshiyama, Riyo Fujiyama, Fumiaki Nakamura
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Influence of mycobacterium tuberculosis strains on recurrence of tuberculosis in Hanoi, Vietnam
Nguyen Hang (Hanoi, Vietnam), Nguyen T.L. Hang, Shinji Maeda, Takayuki Wada, Pham H. Thuong, Nguyen V. Hung, Vu C. Cuong, Nguyen P. Hoang, Shinsaku Sakurada, Minako Hijikata, Ikumi Matsushita, Luu T. Lien, Naoto Keicho
Congress or journal article abstract
Congress or journal article abstract